Evidence map›Paper›PMID 35285626›Full record

ArticleBiochemistry2022

Protonation-Dependent Sequencing of 5-Formylcytidine in RNA.

Courtney N Link, Supuni Thalalla Gamage, Diamond Gallimore, Robert Kopajtich, Christine Evans, Samantha Nance, Stephen D Fox, Thorkell Andresson, Raj Chari, Joseph Ivanic and 2 more

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Transfer RNA acetylation regulates in vivo mammalian stress signaling.bioRxiv : the preprint server for biology · 2024
    Article
  5. The modification landscape ofRNA (New York, N.Y.) · 2024
    Article
  6. Article
  7. The modification landscape ofbioRxiv : the preprint server for biology · 2024
    Article
  8. Cytidine Acetylation Across the Tree of Life.Accounts of chemical research · 2024
    Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Courtney N LinkChemical Biology Laboratory, National Cancer Institute, Frederick, Maryland 21702, United States.
Supuni Thalalla GamageChemical Biology Laboratory, National Cancer Institute, Frederick, Maryland 21702, United States.
Diamond GallimoreChemical Biology Laboratory, National Cancer Institute, Frederick, Maryland 21702, United States.
Robert KopajtichTechnical University Munich, Institute of Human Genetics, München, 81675, Germany.
Christine EvansGenome Modification Core, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland 21702, United States.
Samantha NanceChemical Biology Laboratory, National Cancer Institute, Frederick, Maryland 21702, United States.
Stephen D FoxProtein Characterization Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland 21702, United States.
Thorkell AndressonProtein Characterization Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland 21702, United States.
Raj ChariGenome Modification Core, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland 21702, United States.
Joseph IvanicAdvanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland 21702, United States.ORCID 0000-0003-2104-7169
Holger ProkischTechnical University Munich, Institute of Human Genetics, München, 81675, Germany.
Jordan L MeierChemical Biology Laboratory, National Cancer Institute, Frederick, Maryland 21702, United States.ORCID 0000-0002-0537-7101
Frederick National Laboratory for Cancer Research · USLeidos (United States) · USTechnical University of Munich · DE

Funding

Targeting Cancer Through Modifications and MetabolismZIABC011488 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MEIER, JORDAN L · 2013 to 2025
$21.3M
CCR NIH HHS HHSN261200800001CIntramural NIH HHS ZIA BC011488NCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

Chemical modification of cytidine in noncoding RNAs plays a key role in regulating translation and disease. However, the distribution and dynamics of many of these modifications remain unknown due to a lack of sensitive site-specific sequencing technologies. Here, we report a protonation-dependent sequencing reaction for the detection of 5-formylcytidine (5fC) and 5-carboxycytidine (5caC) in RNA. First, we evaluate how protonation combined with electron-withdrawing substituents alters the molecular orbital energies and reduction of modified cytidine nucleosides, highlighting 5fC and 5caC as reactive species. Next, we apply this reaction to detect these modifications in synthetic oligonucleotides as well as endogenous human transfer RNA (tRNA). Finally, we demonstrate the utility of our method to characterize a patient-derived model of 5fC deficiency, where it enables facile monitoring of both pathogenic loss and exogenous rescue of NSUN3-dependent 5fC within the wobble base of human mitochondrial tRNA

Indexed as

CytidineRNAHumansOligonucleotidesRNA, Transfer5-formylcytidineCytidineOligonucleotidesRNARNA, Transfer

Identifiers

PMID35285626
PMCPMC10518769
OpenAlexW4221051611

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.